Perkins Capital Management’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.68M Sell
203,247
-750
-0.4% -$6.78K 1.58% 17
2025
Q4
$1.96M Sell
203,997
-3,283
-2% -$31K 1.56% 17
2025
Q3
$1.97M Buy
207,280
+37,230
+22% +$313K 1.73% 19
2025
Q2
$1.27M Buy
170,050
+10,750
+7% +$66.7K 1.28% 24
2025
Q1
$969K Sell
159,300
-100
-0.1% -$692 1.02% 30
2024
Q4
$1.24M Buy
159,400
+147,900
+1,286% +$1.1M 1.1% 30
2024
Q3
$93.3K Hold
11,500
0.09% 79
2024
Q2
$79K Hold
11,500
0.07% 85
2024
Q1
$204K Hold
11,500
0.17% 80
2023
Q4
$178K Hold
11,500
0.15% 85
2023
Q3
$158K Hold
11,500
0.16% 82
2023
Q2
$198K Hold
11,500
0.17% 81
2023
Q1
$276K Hold
11,500
0.26% 72
2022
Q4
$200K Hold
11,500
0.21% 79
2022
Q3
$280K Hold
11,500
0.31% 72
2022
Q2
$356K Hold
11,500
0.37% 67
2022
Q1
$401K Hold
11,500
0.33% 74
2021
Q4
$680K Hold
11,500
0.46% 63
2021
Q3
$765K Hold
11,500
0.47% 59
2021
Q2
$726K Sell
11,500
-500
-4% -$28.1K 0.41% 62
2021
Q1
$624K Hold
12,000
0.36% 67
2020
Q4
$527K Hold
12,000
0.34% 61
2020
Q3
$569K Buy
+12,000
New +$486K 0.52% 53
2020
Q1
$1.56M Sell
91,600
-7,500
-8% -$131K 1.89% 18
2019
Q4
$1.63M Sell
99,100
-3,500
-3% -$52.1K 1.46% 21
2019
Q3
$1.68M Sell
102,600
-60,920
-37% -$1.22M 1.45% 22
2019
Q2
$3M Sell
163,520
-10,130
-6% -$161K 2.1% 15
2019
Q1
$2.24M Buy
173,650
+25,750
+17% +$280K 1.48% 20
2018
Q4
$1.63M Sell
147,900
-8,500
-5% -$92.4K 1.26% 19
2018
Q3
$2M Sell
156,400
-500
-0.3% -$7.14K 1.2% 25
2018
Q2
$2.48M Buy
156,900
+31,000
+25% +$330K 1.77% 7
2018
Q1
$1.08M Sell
125,900
-350
-0.3% -$3.09K 0.98% 32
2017
Q4
$1.08M Sell
126,250
-76,740
-38% -$602K 1.04% 34
2017
Q3
$2M Sell
202,990
-184,491
-48% -$1.36M 2.09% 11
2017
Q2
$1.91M Sell
387,481
-23,125
-6% -$75.4K 2.11% 10
2017
Q1
$969K Buy
410,606
+356,061
+653% +$1.17M 1% 30
2016
Q4
$177K Sell
54,545
-6,061
-10% -$14.7K 0.19% 91
2016
Q3
$119K Hold
60,606
0.12% 100
2016
Q2
$126K Hold
60,606
0.14% 94
2016
Q1
$123K Buy
+60,606
New +$106K 0.15% 93

Other funds holding CYRX